Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Hard Copy
Electronic

Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
Business Insights, April 2005, Pages: 186



		Description



		Table of Contents



		Summary



		Companies Mentioned



		Enquire before Buying


	Send to a Friend

Send to a Friend

To email a friend details of Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi complete the form below and click on "Send".

* Required Information

Your Friend's Details

Friend's Full Name *

Friend's Email Address *

A message for your Friend

Your Contact Details

Your Name *

Email Address *

Customers who bought this item also bought

RNAi - Technologies, Markets and Companies

RNAi 2008

Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics

The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics

Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics

Lab on a Chip (LOC) -- Advances in Microfluidics

The Future of RNAi Therapeutics: Drug Pipelines and Prospects

Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery

RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011

The Role of Nanotechnology in European Drug Discovery

RNAi Therapeutics 2008 Market Report

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

Top of page